Evidence map›Paper›PMID 35821255›Full record

ArticleScientific reports2022

Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice.

Dalia S Morsi, Sobhy Hassab El-Nabi, Mona A Elmaghraby, Ola A Abu Ali, Eman Fayad, Shaden A M Khalifa, Hesham R El-Seedi, Islam M El-Garawani

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Chitosan andToxicology research · 2024
    Article
  5. Article
  6. Article
  7. Heliyon · 2023
    Article
  8. Cancers · 2023
    Article
  9. Features and applications of Ehrlich tumor model in cancer studies: a literature review.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2023
    Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Dalia S MorsiZoology Department, Faculty of Science, Menoufia University, Shebin El Kom, 32511, Egypt.
Sobhy Hassab El-NabiZoology Department, Faculty of Science, Menoufia University, Shebin El Kom, 32511, Egypt.
Mona A ElmaghrabyZoology Department, Faculty of Science, Menoufia University, Shebin El Kom, 32511, Egypt.
Ola A Abu AliDepartment of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
Eman FayadDepartment of Biotechnology, Faculty of Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
Shaden A M KhalifaDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, S-106 91, Stockholm, Sweden.
Hesham R El-SeediPharmacognosy Group, Biomedical Centre, Department of Pharmaceutical Biosciences, Uppsala University, P.O. Box 591, 752 24, Uppsala, SE, Sweden. hesham.el-seedi@farmbio.uu.se.
Islam M El-GarawaniZoology Department, Faculty of Science, Menoufia University, Shebin El Kom, 32511, Egypt. dr.garawani@science.menofia.edu.eg.
Menoufia University · EGTaif University · SAJiangsu University · CNStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cinnamon is a well-known natural spice and flavoring substance used worldwide. The objective of the present work is to explore the possible antitumor and immunomodulatory potencies of cinnamon essential oil (Cinn) on Ehrlich ascites carcinoma (EAC). A total of fifty female Swiss albino mice were sub-grouped into five groups (n = 10), namely, normal (a non-tumorized and non-treated) group; EAC-tumorized and non-treated group; Cinn (non-tumorized mice received Cinn, 50 mg/kg per body weight daily) group; a group of EAC-tumorized mice treated with Cinn and the final positive control group of EAC-tumorized mice received cisplatin. Eight compounds were identified from Cinn using UPLC-MS-Qtof and NMR analysis. Compared to EAC untreated group, Cinn successfully (P < 0.05) inhibited tumor growth by reducing tumor cell count (45%), viability (53%) and, proliferation accompanied by the inhibition of tumor growth rate. Moreover, a significant (P < 0.05) arrest in the cell cycle at G

Indexed as

Antineoplastic Agents, PhytogenicCarcinoma, Ehrlich TumorOils, VolatileAnimalsAscitesChromatography, LiquidCinnamomum zeylanicumFemaleImmunityMiceMice, Inbred StrainsTandem Mass SpectrometryAntineoplastic Agents, PhytogenicOils, Volatile

Identifiers

PMID35821255
PMCPMC9276696
OpenAlexW4285094424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.